A novel contrastive learning approach utilizing pathological prior knowledge for improved classification of histological types in lung squamous cell carcinoma
By
Mingci Huang
Weijin Xiao
Gen Lin
Chao Li
Haipeng Xu
Yunjian Huang
Shengjia Chen
Chuanben Chen
Yang Sun
Qiaofeng Zhong
December 17, 2025
Clinical Scorecard: A novel contrastive learning approach utilizing pathological prior knowledge for improved classification of histological types in lung squamous cell carcinoma
At a Glance
Category Detail
Condition Lung Squamous Cell Carcinoma Key Mechanisms Contrastive self-supervised learning with pathological prior knowledge Target Population Patients with lung squamous cell carcinoma requiring histopathological analysis Care Setting Pathology laboratories and clinical diagnostic settings
Key Highlights
Weakly supervised learning reduces annotation costs and complexity in histopathological analysis. Multiple Instance Learning (MIL) is widely used but has limitations in fine-grained tissue analysis. Contrastive learning optimizes feature representations but faces challenges with ultra-high-resolution WSIs. Guideline-Based Recommendations
Diagnosis
Utilize digital pathology and computational methods for accurate cancer diagnosis. Management
Implement weakly supervised and self-supervised learning techniques for efficient feature extraction. Monitoring & Follow-up
Regularly assess the quality of annotations and model performance in pathological analysis. Risks
Inconsistencies in annotations can negatively impact model accuracy. Patient & Prescribing Data
Individuals diagnosed with lung squamous cell carcinoma requiring histopathological evaluation.
Leveraging advanced computational techniques can enhance diagnostic accuracy.
Clinical Best Practices
Adopt self-supervised learning approaches to improve feature extraction from WSIs. Ensure high-quality annotations to support model training and validation. References
